News archive

Australians with epilepsy are turning to cannabis products when antiepileptic drug side-effects are intolerable and epilepsy uncontrolled.

Analysis from the University of Sydney Business School has found that legalising medicinal cannabis in Australia could create a new industry worth more than $100 million per year. 

A clinical trial using a new form of cannabis developed by the University of Sydney’s Lambert Initiative will assess the use of the drug to prevent nausea and vomiting in people undergoing chemotherapy.

What are the difficulties of using medicinal cannabis in Australia? Professor Iain McGregor from the University's Lambert Initiative explains in this article originally published on the Sydney Morning Herald.